South Africa’s medical tourism pitch is easy to summarise: good private hospitals, prices well below Europe, and a market forecast that more than quadruples inside a decade. The forecast comes from IMARC Group, and it circulates through press releases and aggregator sites, usually secondhand and usually without anyone checking it against South Africa’s own border statistics. I did the checking. The two sets of numbers do not describe the same country.
What the market reports claim
IMARC Group’s current report values the South Africa medical tourism market at $771.5 million in 2025 and projects $3,444.9 million by 2034, a compound annual growth rate of 17.55 percent. It segments the trade into cosmetic, dental, cardiovascular, orthopaedic, bariatric, fertility and ophthalmic work, concentrated in Gauteng, the Western Cape and KwaZulu-Natal. An earlier edition of the same report, still the version most derivative articles quote, put the market at $648.09 million in 2024 and $3,110.77 million by 2033, growing at 19.04 percent a year. The recent developments cited as evidence are modest: an April 2025 booking partnership between Satguru Travel Group and the medical travel platform Healthtrip, and a longevity summit in Durban.
Two things are worth noticing before any of this reaches a business plan. First, the forecast moved between editions: the growth rate dropped by about a point and a half and the horizon shifted a year. That is normal in market research, and it is a useful reminder that these figures are model outputs, not measurements. Second, the evidence base is thin. A booking tie-up and a conference are what you cite when audited patient revenue does not exist. Nobody in this market publishes the number that would settle the question, so a projection fills the vacuum and hardens into fact through repetition.
What the border data shows
Statistics South Africa’s Tourism 2024 report, compiled from Department of Home Affairs immigration records, counted 8,919,370 foreign tourists in 2024, up 5.1 percent on 2023 and still 12.8 percent below the pre-pandemic peak. Of those, 96.9 percent came on holiday. Exactly 3,049 tourists, less than 0.1 percent, declared medical treatment as their purpose of visit: 1,957 from SADC countries, 628 from overseas and 447 from the rest of Africa. Another 204 same-day visitors crossed for treatment. The busiest months brought 334 and 309 medical arrivals respectively. Yet IMARC’s report states that 27,458 foreign visitors cited medical purposes when entering South Africa by July 2024, a figure that has been recycled through derivative coverage, including an earlier version of this article. I could not find it in any Stats SA publication, and the official monthly series contradicts it: at a peak rate of 334 arrivals a month, seven months gets you past 2,000, not past 27,000.
Divide honestly and the problem gets worse. A $771.5 million market spread across 3,049 declared medical tourists is roughly $253,000 per patient, which is absurd. Even against the unsourced 27,458 it is about $28,000 per visitor, far above what dental work or cataract surgery in Johannesburg costs. The academic literature supplies the missing piece. Jonathan Crush and Abel Chikanda, writing in Social Science and Medicine, documented that patient movement into South Africa is overwhelmingly regional, much of it informal, driven by absent care at home, and large enough that the government has tried to formalise it through inter-country agreements with its neighbours. In other words, the official count is certainly too low, because most patients from the region never declare themselves at the border. But that cuts both ways: if the real flow is informal and uncounted, then any revenue figure quoted to two decimal places is a guess wearing a decimal point.
The hospitals are real
Whatever the patient numbers, the supply side checks out. Netcare, one of South Africa’s three big private hospital groups, lists 49 acute hospitals with 9,827 registered beds in its 2024 hospital listings, from Christiaan Barnard Memorial in Cape Town to Milpark in Johannesburg, plus another 1,007 mental health beds under its Akeso brand. Gauteng alone holds 5,585 of those acute beds, which matches IMARC’s claim that the province anchors the trade. Mediclinic and Life Healthcare run the other two large networks.
I went looking for an international patient count in Netcare’s public reporting and did not find one. Beds are itemised hospital by hospital, down to the 21-bed Umhlanga Eye Institute; foreign patients are not counted anywhere. That absence is its own data point. For the groups that would actually treat medical travellers, the trade is evidently not material enough to report. The clinical capacity behind the pitch is real, the region’s patients demonstrably use it, and there is still no audited number connecting the two. Until one of the big three gives international revenue a line in its results, every market size for South African medical tourism is an estimate built on estimates.
The wellness numbers are a different market
Search interest often lands on the phrase “South Africa health and wellness market”, and that figure exists too: IMARC puts it at $27.9 billion in 2025, reaching $42.5 billion by 2034 at 4.56 percent a year. Read the segmentation before quoting it, because it covers functional foods and beverages, beauty and personal care, and preventive medicinal products. It is a consumer goods market, not a travel market, and gluing it onto a medical tourism story multiplies the sector thirtyfold by sleight of hand. South African Tourism, for its part, is selling wellness without the spreadsheet. In August 2025 it published “Wellness Reimagined: Soulful South African Journeys”, a campaign built on indigenous healing plants, mineral springs at Tshipise and the Caledon, and retreats like Sterrekopje Healing Farm. Three weeks later, South African Tourism and the KwaZulu-Natal Tourism and Film Authority hosted the 4th International Longevity Summit at Sibaya near Durban, drawing some 300 delegates under the theme “Future-Proofing Health: Africa’s Role in the Global Longevity Revolution”.
The wellness pitch is, oddly, the more credible of the two. It sells what the country demonstrably has - landscape, springs, retreats and a tourism industry that moved almost nine million people in 2024 - and it does not depend on a patient count nobody can audit. A longevity summit is brand-building, but it is honest brand-building. If KwaZulu-Natal keeps stacking these events, the wellness traveller may end up doing more for provincial tourism revenue than the medical patient the market reports keep projecting.
What This Means
South Africa has real hospitals, real regional demand and soft numbers. The border data understates the trade because most of it is informal; the market reports overstate its precision because a forecast is all there is; and the 27,458 figure that launched a hundred articles has no visible source in the official statistics. If I were a facilitator or an investor, I would treat Stats SA’s 3,049 as the floor, treat IMARC’s projection as marketing, and watch for two signals that the market is maturing. The first is a proper count: the inter-country agreements Crush and Chikanda describe would give the government a reason to publish one. The second is a hospital group breaking out international patient revenue. The day Netcare or one of its rivals puts that line in its results, South African medical tourism will finally have a number worth quoting. Until then, the honest answer to “how big is the market” is: nobody has measured it.
